{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:13:55Z","timestamp":1788092035798,"version":"build-2803163510"},"posted":{"date-parts":[[2026,8,4]]},"group-title":"In Review","reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,25]]},"abstract":"<title>Abstract<\/title>\n                <p>A meta-analysis of the existing literature was conducted to quantify breast cancer risk according to histologic subtype of benign breast disease (BBD) among women of diverse racial and ethnic backgrounds worldwide. PubMed (Medline), EMBASE (Emtree), and other relevant biomedical databases were searched through February 2026 to identify studies reporting the development of subsequent breast cancer in women diagnosed with either nonproliferative disease (NP), proliferative disease without atypia (PDWA), or atypical hyperplasia (AH). Seven studies met the eligibility criteria. Women of Asian ancestry with PDWA or AH had a substantially higher risk of breast cancer than those with NP. Among Black women, breast cancer risk associated with BBD subtypes was comparable to historically reported risks among White women, whereas associations among Hispanic women were less clear due to greater data limitations. The variable BBD-associated breast cancer risk across racial groups warrants confirmation and underscores the need for further investigation of the mechanisms underlying these differences.<\/p>","DOI":"10.21203\/rs.3.rs-10475905\/v1","type":"posted-content","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:33:01Z","timestamp":1785857581000},"source":"Crossref","is-referenced-by-count":0,"title":["Breast Cancer Risk After Benign Breast Disease Among Racially Diverse Women: Systematic Review and Meta-Analysis"],"prefix":"10.21203","author":[{"given":"Alzina","family":"Koric","sequence":"first","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat","family":"Preema","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila","family":"Anandarajah","sequence":"additional","affiliation":[{"name":"Vanderbilt University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Patel","sequence":"additional","affiliation":[{"name":"St. Joseph Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hardi","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A.","family":"Colditz","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","first-page":"1","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","author":"Kim J","year":"2025","unstructured":"Kim J, Harper A, McCormack V, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nature Medicine. 2025:1\u20139.","journal-title":"Nature Medicine."},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1038\/npjbcancer.2015.9","article-title":"Preventing breast cancer now by acting on what we already know","volume":"1","author":"Colditz GA","year":"2015","unstructured":"Colditz GA, Bohlke K. Preventing breast cancer now by acting on what we already know. NPJ Breast Cancer. 2015;1(1):15009.","journal-title":"NPJ Breast Cancer."},{"key":"ref3","article-title":"SEER cancer statistics review, 1975\u20132011","author":"Howlader N","year":"2014","unstructured":"Howlader N, Noone A-M, Krapcho M, et al. SEER cancer statistics review, 1975\u20132011. National Cancer Institute. 2014.","journal-title":"National Cancer Institute"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41523-024-00703-w","article-title":"A systematic review of determinants of breast cancer risk among women with benign breast disease","volume":"11","author":"Burke A","year":"2025","unstructured":"Burke A, O\u2019Driscoll J, Abubakar M, et al. A systematic review of determinants of breast cancer risk among women with benign breast disease. npj Breast Cancer. 2025;11(1):16.","journal-title":"npj Breast Cancer."},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10549-017-4347-9","article-title":"Association between lifestyle, menstrual\/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease","volume":"165","author":"Arthur R","year":"2017","unstructured":"Arthur R, Wang Y, Ye K, et al. Association between lifestyle, menstrual\/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease. Breast Cancer Res Treat. 2017;165(3):623\u2013631.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41523-021-00225-9","article-title":"The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease","volume":"7","author":"Beca F","year":"2021","unstructured":"Beca F, Oh H, Collins LC, Tamimi RM, Schnitt SJ. The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease. NPJ Breast Cancer. 2021;7(1):23.","journal-title":"NPJ Breast Cancer."},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cncr.22408","article-title":"Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study","volume":"109","author":"Collins LC","year":"2007","unstructured":"Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer. 2007;109(2):180\u2013187.","journal-title":"Cancer."},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13058-021-01410-1","article-title":"Risk factors for breast cancer development by tumor characteristics among women with benign breast disease","volume":"23","author":"Figueroa JD","year":"2021","unstructured":"Figueroa JD, Gierach GL, Duggan MA, et al. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease. Breast Cancer Res. 2021;23(1):34.","journal-title":"Breast Cancer Res."},{"issue":"6","key":"ref9","first-page":"821","article-title":"A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer","volume":"21","author":"Kabat GC","year":"2010","unstructured":"Kabat GC, Jones JG, Olson N, et al. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control. 2010;21(6):821\u2013828.","journal-title":"Cancer Causes Control."},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/1940-6207.CAPR-12-0175","article-title":"Benign breast disease and the risk of subsequent breast cancer in African American women","volume":"5","author":"Cote ML","year":"2012","unstructured":"Cote ML, Ruterbusch JJ, Alosh B, et al. Benign breast disease and the risk of subsequent breast cancer in African American women. Cancer Prev Res (Phila). 2012;5(12):1375\u20131380.","journal-title":"Cancer Prev Res (Phila)."},{"key":"ref11","first-page":"djag048","article-title":"Subsequent breast cancer risk after benign biopsy in racially diverse women: Siteman Cancer Center","author":"Koric A","year":"2026","unstructured":"Koric A, Bennett DL, Boulos F, Colditz GA. Subsequent breast cancer risk after benign biopsy in racially diverse women: Siteman Cancer Center. JNCI: Journal of the National Cancer Institute. 2026:djag048.","journal-title":"JNCI: Journal of the National Cancer Institute."},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/1055-9965.EPI-24-0204","article-title":"Understanding Benign Breast Disease and Subsequent Breast Cancer in Hispanic White Females: A Step Closer to Evidence-Based Management","volume":"33","author":"Lohani KR","year":"2024","unstructured":"Lohani KR, Nibbe AM, Vierkant RA, et al. Understanding Benign Breast Disease and Subsequent Breast Cancer in Hispanic White Females: A Step Closer to Evidence-Based Management. Cancer Epidemiol Biomarkers Prev. 2024;33(8):1107\u20131113.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.breast.2020.09.005","article-title":"Differences in breast cancer risk after benign breast disease by type of screening diagnosis","volume":"54","author":"Louro J","year":"2020","unstructured":"Louro J, Roman M, Posso M, et al. Differences in breast cancer risk after benign breast disease by type of screening diagnosis. Breast. 2020;54:343\u2013348.","journal-title":"Breast."},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1349-7006.1993.tb00181.x","article-title":"Benign breast disease as a breast cancer risk in Japanese women","volume":"84","author":"Nomura Y","year":"1993","unstructured":"Nomura Y, Tashiro H, Katsuda Y. Benign breast disease as a breast cancer risk in Japanese women. Japanese journal of cancer research. 1993;84(9):938\u2013944.","journal-title":"Japanese journal of cancer research."},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1349-7006.1999.tb00789.x","article-title":"Risk of breast cancer in Japanese women with benign breast disease","volume":"90","author":"Minami Y","year":"1999","unstructured":"Minami Y, Ohuchi N, Taeda Y, et al. Risk of breast cancer in Japanese women with benign breast disease. Japanese journal of cancer research. 1999;90(6):600\u2013606.","journal-title":"Japanese journal of cancer research."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1410819","DOI":"10.3389\/fonc.2024.1410819","article-title":"Multiplicity of benign breast disease lesions and breast cancer risk in African American women","volume":"14","author":"Patil V","year":"2024","unstructured":"Patil V, Ruterbusch JJ, Chen W, et al. Multiplicity of benign breast disease lesions and breast cancer risk in African American women. Front Oncol. 2024;14:1410819.","journal-title":"Front Oncol."},{"key":"ref17","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj. 2021;372.","journal-title":"bmj."},{"key":"ref18","unstructured":"Covidence systematic review software. In. Melbourne, Australia: Veritas Health Innovation."},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I","article-title":"Breast cancer risk associated with proliferative breast disease and atypical hyperplasia","volume":"71","author":"Dupont WD","year":"1993","unstructured":"Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71(4):1258\u20131265.","journal-title":"Cancer."},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease","volume":"312","author":"Dupont WD","year":"1985","unstructured":"Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. New England Journal of Medicine. 1985;312(3):146\u2013151.","journal-title":"New England Journal of Medicine."},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo SP","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC medical research methodology. 2005;5(1):13.","journal-title":"BMC medical research methodology."},{"issue":"7414","key":"ref22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins JP","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. bmj. 2003;327(7414):557\u2013560.","journal-title":"bmj."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/9781119536604.ch10","article-title":"Analysing data and undertaking meta-analyses","author":"Deeks JJ","year":"2019","unstructured":"Deeks JJ, Higgins JP, Altman DG, Group CSM. Analysing data and undertaking meta-analyses. Cochrane handbook for systematic reviews of interventions. 2019:241\u2013284.","journal-title":"Cochrane handbook for systematic reviews of interventions."},{"key":"ref24","first-page":"B-10","article-title":"Newcastle-Ottawa quality assessment scale cohort studies","author":"Wells G","year":"2014","unstructured":"Wells G, Shea B, O\u2019connell D, et al. Newcastle-Ottawa quality assessment scale cohort studies. University of Ottawa. 2014:B-10.","journal-title":"University of Ottawa."},{"issue":"4_Supplement","key":"ref25","doi-asserted-by":"crossref","first-page":"P2","DOI":"10.1158\/1538-7445.SABCS21-P2-11-12","article-title":"Abstract P2-11-12: Benign breast disease and breast malignancy","volume":"82","author":"Ter-Minassian M","year":"2022","unstructured":"Ter-Minassian M, Somasundaram B, Visvanathan K. Abstract P2-11-12: Benign breast disease and breast malignancy. Cancer Res. 2022;82(4_Supplement):P2-11-12-P12-11-12.","journal-title":"Cancer Res."},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1524-4741.2007.00388.x","article-title":"Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population","volume":"13","author":"Worsham MJ","year":"2007","unstructured":"Worsham MJ, Abrams J, Raju U, et al. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J. 2007;13(2):115\u2013121.","journal-title":"Breast J."},{"key":"ref27","author":"Ang WW","year":"2024","unstructured":"Ang WW, Jung J-J. Abstract PO3-07-09: B3 breast lesions in Asian Centers: malignant upgrade rates and risk factors. Cancer Res. 2024;84(9_Supplement):PO3-07-09-PO03-07-09."},{"issue":"6","key":"ref28","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto AN","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA, et al. Breast cancer statistics 2024. CA: a cancer journal for clinicians. 2024;74(6):477\u2013495.","journal-title":"CA: a cancer journal for clinicians."},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/1055-9965.EPI-23-0049","article-title":"Impact of BMI on prevalence of dense breasts by race and ethnicity","volume":"32","author":"Kerlikowske K","year":"2023","unstructured":"Kerlikowske K, Bissell MC, Sprague BL, et al. Impact of BMI on prevalence of dense breasts by race and ethnicity. Cancer Epidemiology, Biomarkers & Prevention. 2023;32(11):1524\u20131530.","journal-title":"Cancer Epidemiology, Biomarkers & Prevention."},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"e1002335","DOI":"10.1371\/journal.pmed.1002335","article-title":"Mammographic density and ageing: a collaborative pooled analysis of cross-sectional data from 22 countries worldwide","volume":"14","author":"Burton A","year":"2017","unstructured":"Burton A, Maskarinec G, Perez-Gomez B, et al. Mammographic density and ageing: a collaborative pooled analysis of cross-sectional data from 22 countries worldwide. PLoS medicine. 2017;14(6):e1002335.","journal-title":"PLoS medicine."},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13058-024-01885-8","article-title":"Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome","volume":"26","author":"Strand SH","year":"2024","unstructured":"Strand SH, Houlahan KE, Branch V, et al. Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome. Breast Cancer Research. 2024;26(1):127.","journal-title":"Breast Cancer Research."},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/cncr.29199","article-title":"Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium","volume":"121","author":"Allison KH","year":"2015","unstructured":"Allison KH, Abraham LA, Weaver DL, et al. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium. Cancer. 2015;121(9):1369\u20131378.","journal-title":"Cancer."},{"issue":"33","key":"ref33","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.19.01472","article-title":"Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update","volume":"37","author":"Visvanathan K","year":"2019","unstructured":"Visvanathan K, Fabian CJ, Bantug E, et al. Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update. Journal of clinical oncology. 2019;37(33):3152\u20133165.","journal-title":"Journal of clinical oncology."},{"key":"ref34","unstructured":"National Comprehensive Cancer Network Clinical Guidelines in Oncology (NCCN Guidelines\u00ae). Breast Cancer Risk Reduction. 2025; Version 1.2026 Accessed 7\/24\/2026, 2026."},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1245\/s10434-018-6584-5","article-title":"Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely((R)) Campaign","volume":"25","author":"Rao R","year":"2018","unstructured":"Rao R, Ludwig K, Bailey L, et al. Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely((R)) Campaign. Ann Surg Oncol. 2018;25(10):2795\u20132800.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann LC","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. New England Journal of Medicine. 2005;353(3):229\u2013237.","journal-title":"New England Journal of Medicine."},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jama.1992.03480070057030","article-title":"A Prospective-Study of Benign Breast Disease and the Risk of Breast-Cancer","volume":"267","author":"London SJ","year":"1992","unstructured":"London SJ, Connolly JL, Schnitt SJ, Colditz GA. A Prospective-Study of Benign Breast Disease and the Risk of Breast-Cancer. Jama-J Am Med Assoc. 1992;267(7):941\u2013944.","journal-title":"Jama-J Am Med Assoc."},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jamasurg.2023.6382","article-title":"Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era","volume":"159","author":"Sherman ME","year":"2024","unstructured":"Sherman ME, Vierkant RA, Winham SJ, et al. Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era. JAMA Surg. 2024;159(2):193\u2013201.","journal-title":"JAMA Surg."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10475905\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10475905\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:25:32Z","timestamp":1788089132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10475905\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":38,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10475905\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,8,4]]},"subtype":"preprint"}}